

ImmuniWeb and Cortex Xpanse are competing in the cybersecurity field. Although Cortex Xpanse holds an edge with a robust feature set and high customer satisfaction, ImmuniWeb impresses with pricing and support.
Features: ImmuniWeb offers advanced vulnerability assessments, comprehensive monitoring, and a zero false-positive SLA. Cortex Xpanse provides extensive internet asset discovery, risk assessment features, and real-time attack surface management, offering detailed insights into potential threats.
Room for Improvement: ImmuniWeb could expand language options and integrate more with non-English markets. Users suggest improving its user interface and real-time reporting capabilities. Cortex Xpanse could benefit from streamlining deployment processes and providing more extensive user training. Its user interface might be enhanced to improve personalization for varying user needs.
Ease of Deployment and Customer Service: ImmuniWeb is known for a streamlined deployment process with strong support, ideal for quick setup. Cortex Xpanse requires more time for deployment due to its feature set, but its responsive customer service helps address challenges faced during implementation.
Pricing and ROI: ImmuniWeb is cost-effective with a strong ROI through its affordable pricing model. Cortex Xpanse may involve higher initial setup costs, but its investment justifies the price by offering comprehensive threat visibility, enhancing the long-term security posture.
| Product | Market Share (%) |
|---|---|
| Cortex Xpanse | 2.9% |
| ImmuniWeb | 0.7% |
| Other | 96.4% |


| Company Size | Count |
|---|---|
| Small Business | 4 |
| Midsize Enterprise | 1 |
| Large Enterprise | 2 |
Xpanse provides a complete, accurate and continuously updated inventory of all global internet-facing assets. This allows you to discover, evaluate, and mitigate cyber attack surface risks. You can also evaluate supplier risk and assess the security of acquired companies.
Manual asset inventory maintenance is slow and prone to error. An outside-in view of your attack surface catches assets and exposures you never knew existed to help with attack surface reduction.
Get ahead of your ransomware risk assessment by discovering and remediating RDP exposures, the leading attack vector in ransomware attacks. Find exposed assets before attackers do.
Integration with Cortex XSOAR, Prisma Cloud, and our broader portfolio allows our ASM findings to enhance security workflows, and secure unknown, unmanaged risks on your cloud attack surface.
ImmuniWeb is a global application security company operating in over 50 countries, headquartered in Geneva, Switzerland. Most of ImmuniWeb's customers come from regulated industries, such as banking, healthcare, and e-commerce.
ImmuniWeb® AI Platform leverages award-winning AI and Machine Learning technology for acceleration and intelligent automation of Attack Surface Management and Dark Web Monitoring. The data is later leveraged for threat-aware and risk-based Application Penetration Testing for web, mobile, and API security testing. ImmuniWeb is the only company that offers a contractual zero false-positives SLA with a money-back guarantee. ImmuniWeb’s AI technology is a recipient of numerous awards and recognitions, including Gartner Cool Vendor, IDC Innovator, and the winner of “SC Award Europe” in the “Best Usage of Machine Learning and AI” category.
ImmuniWeb® Community Edition runs over 100,000 daily tests, being one of the largest application security communities. ImmuniWeb SA is an ISO 27001 certified and CREST-accredited company.
We monitor all Attack Surface Management (ASM) reviews to prevent fraudulent reviews and keep review quality high. We do not post reviews by company employees or direct competitors. We validate each review for authenticity via cross-reference with LinkedIn, and personal follow-up with the reviewer when necessary.